scispace - formally typeset
Open AccessJournal ArticleDOI

Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection

Reads0
Chats0
TLDR
The results suggest that PD1 and Tim3 markers of exhaustion have a pivotal role in CD4 dynamics in HIV patients and its down-regulation would be a desirable effect of immunotherapies aimed to restore CD4 T-cell pool during progression of HIV infection.
Abstract
Introduction T-cell exhaustion has been involved in the pathogenesis of HIV infection. We have longitudinally analyzed PD1 and Tim3 surrogate markers of T-cells exhaustion, in parallel with other markers of HIV progression, and its potential association with CD4 changes in treated and untreated infection. Patients and methods 96 HIV patients, 49 of them followed in the absence of cART (cART-naive group) and 47 after initiation of cART (cART group) were included and followed for a median of 43 [IQR: 31-60] months. PD1 and Tim3 expression, CD8 T-cells activation, recent thymic emigrants, activation/apoptosis and turnover of CD4 cells were assessed at baseline and during follow up. Univariate and multivariate associations with CD4 evolution were explored. Results Parameters significantly associated with CD4 depletion in cART-naive group were: baseline level (p = 0.02) and variation (p = 0.002) of PD1 and Tim3 co-expression on CD8, and variation of CD95 expression on CD4 (p = 0.007). Parameters significantly associated with CD4 restoration in cART group were: baseline level of CD38+HLADR- subset of CD8 (p = 0.01), variation of PD1 expression on CD8 (p = 0.036), variation of Tim3 expression on CD4 (p = 0.039) and variation of CD95 expression on CD4 (p = 0.035). Conclusions Our results suggest that PD1 and Tim3 markers of exhaustion have a pivotal role in CD4 dynamics in HIV patients and its down-regulation would be a desirable effect of immunotherapies aimed to restore CD4 T-cell pool during progression of HIV infection.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

CD4 T-Cell Exhaustion: Does It Exist and What Are Its Roles in Cancer?

TL;DR: In this paper, the authors discuss mechanistic and clinical evidence for CD4 T-cell exhaustion in cancer and reveal novel therapeutic targets to abrogate CD4T-cell depletion in cancer.
Journal ArticleDOI

Memory CD4 + T-Cells Expressing HLA-DR Contribute to HIV Persistence During Prolonged Antiretroviral Therapy.

TL;DR: The research revealed that cellular transition and proliferation contribute to the persistence of HIV in HLA-DR+ and Hla-DR− T-cell subsets during prolonged therapy, and therapeutic interventions aimed at reducing the HIV-1 reservoir should target H LA-DR+.
Journal ArticleDOI

Immune Checkpoints in Viral Infections

TL;DR: Recent findings regarding immune checkpoints in viral infections, including COVID-19, are reviewed and the potential for applying immune checkpoint blockades as antiviral therapy is discussed.
Journal ArticleDOI

Targeting Immune Checkpoint Molecules to Eliminate Latent HIV.

TL;DR: Treatment with immune checkpoint (IC) molecules has been associated with toxicities such as immune-related adverse events and therefore future studies should proceed with caution, but the potential for this therapeutic to be utilized as a latency reversing agent remains.
References
More filters
Journal ArticleDOI

Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function

TL;DR: The persistence of activated virus-specific CD8 T cells without effector function reveals a novel mechanism for silencing antiviral immune responses and also offers new possibilities for enhancingCD8 T cell immunity in chronically infected hosts.
Journal ArticleDOI

Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection

TL;DR: T cell exhaustion was progressive, and gene-expression profiling indicated that T cell exhaustion and anergy were distinct processes, which provides a framework for designing rational immunotherapies during chronic infections.
Journal ArticleDOI

PD-1 is a regulator of virus-specific CD8+ T cell survival in HIV infection.

TL;DR: PD-1 is a major regulator of apoptosis that can impact the frequency of antiviral T cells in chronic infections such as HIV, and could be manipulated to improve HIV-specific CD8+ T cell numbers, but possibly not all functions in vivo.
Related Papers (5)